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Abstract 
The discovery of hepatitis B virus (HBV) infection among long-tailed macaques from Mauritus Island in 2013 is 
a new finding that showed HBV could infect non-human primate family Cercopithecidae. The aim of this study 
is to investigate the prevalence of Hepadnavirus among Macaca fascicularis that are living outside of their 
natural habitat in Indonesia. Hepatitis B surface antigen (HBsAg) screening test was performed on 95 plasma 
and serum samples collected from the different sources captivity, confiscated long-tailed macaques, and 
performance monkey. DNA detection was carried out on seropositive samples to HBsAg. Screening test showed 
that 11 of 95 (11.6%) samples were reactive to HBsAg. Prevalence of HBsAg is higher in confiscated animals 
and performance monkey (55%) compared with captive M. fascicularis (45%). However, no HBV DNA could 
be detected in HBsAg samples that were tested. HBsAg positive result indicate that the long-tailed macaques 
could be infected by hepatitis B virus naturally, although HBV DNA could not be detected in this study. 
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1. Introduction (use bold for main headings like this one. do not use italic) 
Hepatitis is a general term meaning inflammation of the liver and can be caused by a viral infection [1]. Viral 
hepatitis disease is a major cause of cirrhosis and liver cancer [2]. One of the viruses that causes hepatitis in 
humans, leading to a major global impact is hepatitis B virus (HBV) [1]. Hepatitis B virus comes from the 
family Hepadnaviridae. Hepadnaviridae can be found in aves (avihepadnavirus), and mammals 
(orthohepadnavirus) especially primates [3]. Hepatitis B infection have a high degree of endemicity in 
Indonesia, with positive 9.4% HBsAg prevalence of the 10391 serum samples, it showed that among 10 people 
in Indonesia there is 1 people infected by Hepatitis B virus [4]. Among the member countries of SEAR WHO 
(World Health Organization South-East Asian Region) Indonesia is the second country with the most cases of 
Hepatitis B after Myanmar [4]. Although HBV is generally known as a disease in the human population, only 
few studies have published the prevalence of HBV in primate species, particularly primates in captivity and 
infected by humans [5, 6]. In the natural habitat, non-human primate HBV infection has been identified in 
gibbon (GiHBV), orangutan (OuHV), chimpanzees (ChHBV), gorilla (GoHBV), and woolly monkey 
(WMHBV) [7, 8]. Various studies suggest that hepadnavirus in non-human primate species are genetically 
distinct from human HBV [7, 9]. Among the high prevalence of hepatitis B infection in apes and Atelidae 
(woolly monkey), there have been no reports of HBV infection that have occured in small primates 
Cercopithecidae. Until 2013, there are reports findings of hepadnavirus that are genetically close to human HBV 
in long-tailed macaque (Macaca fascicularis) from Mauritius Island [10]. More recently, a study in performance 
monkeys conducted to survey various pathogenic disease agents include hepatitis B, in the area of Jakarta, West 
Java and Central Java. The results showed that antibodies against hepatitis B were detected as much as 8.9% 
(4/45), but from all of the seropositive samples, DNA hepatitis B virus is undetectable [11]. In addition to living 
in the primary and secondary forests, long-tailed macaques can be found coexisting with humans in many 
habitats, such as in the agricultural areas, villages, tourist areas, religious sites, and also used as a pet, and 
entertainment commodity such as performance monkey [12, 13]. Long-tailed macaques are known to live 
sympatric with other primates such as gibbons, orangutans, and Thomas’s langur [14]. The possibility of 
physical contact with the long-tailed macaques to humans and other primate species allows the transmission of 
various agents of diseases, including viral hepatitis B. The hepatitis B virus can be transmitted through direct 
contact with blood and body fluids contaminated with HBV [1]. Detection of HBV infection can be done 
through serological examination of the surface antigen and antibodies to HBV by ELISA, but despite of that 
HBV viral DNA can also be detected through the polymerase chain reaction (PCR) [5, 10] . Hepatitis B chronic 
disease management is generally a long, costly, only partially effective and often lead to the emergence of 
resistant variants [15]. Currently, the approach in immunotherapy are expected to restore humoral immune 
responses that are specific to this case, but in terms of biomedical research, small primate species suitable as an 
animal model of hepatitis B virus are still not discovered yet [16, 10]. The authors in [10, 11] noted that HBV 
infections have been reported in long-tailed macaques. However, a lot of data and information is needed in 
identifying and proving that the long-tailed macaques in Indonesia can become infected with HBV. Long-tailed 
macaque widely distributed in natural habitats and around civil society, the research about the presence of HBV 
in the long-tailed macaque is indispensable. The purpose of this study was to investigate and determine the 
prevalence Hepadnavirus on a long-tailed macaques. In this study, samples taken from ex-situ institutions that 
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handle long-tailed macaques, both in breeding facilities and wildlife rehabilitation centers. 
2. Materials and methods 
2.1. Sample collection and processing  
Total of 91 of serum and plasma samples were collected from two primate facilities in Bogor, West Java and 4 
of plasma samples were obtained from performance monkeys in Solo, Central Java.   Blood samples were taken 
during routine medical examination in those facilities except for samples from performance monkeys were 
collected during pathogen surveillance for its population. Blood samples were collected in plain tubes or EDTA-
tubes and the serum or plasma was separated by centrifugation at 3000 xg for 20 min and then analyzed or 
stored at -80 °C until serological tests were performed. Processing and laboratory analysis were conducted at the 
Laboratory of Biotechnology, and Laboratory Microbiology Immunology of PRC-IPB.   
2.2. Serology test for HBsAg 
Detection of Hepatitis B surface antigen (HBsAg) was carried out using commercial ELISA kit (HBsAg ™, 
Human®, Human fȕr Biochemica Gesellschaft und Diagnostica mbH, Germany) according to manufacturer’s 
instruction manual. Briefly 50 ul serum or plasma samples, positive and negative controls were added into 
antibody-coated plates and Horseradish peroxidase-conjugated anti-HBsAg (Guinea pig) was then incubated for 
80 minutes at 37oC. Tetramethyl benzidine (TMB) substrate was added for 30 min at room temperature for color 
development.  The reaction was stopped by adding Sulphuric acid and optical density was measured at 450 nm 
using ELISA reader.  The Cut-off value (COV) were calculated by adding 0.025 to the mean value of the 
negative control  
2.3. DNA extraction 
Total DNA was extracted from serum or plasma samples using the QIAamp DNA blood mini kit  (Qiagen, US) 
according to the manufacturer’s instructions. The quality of DNA were further evaluated by performing the PCR 
amplification to GAPDH housekeeping gene.   
2.4. Procedure Polymerase Chain Reaction (PCR) and electrophoresis 
Polymerase Chain Reaction were performed in Thermal cycler Applied Biosystem 9700 using primer sequences 
developed by author in [7].  Primers was designed to amplify the Pre-S1 region  and were used to detect HBV in 
orangutans and the Javan gibbon species [7, 17, 18].  The master mix for PCR consisted of 12.5 µL KAPA Taq 
HotStart ™ Readymix (containing 1U KAPA Taq DNA polymerase, KAPA Taq buffer, 0.2 mM dNTPs, and 
1.5mM MgCl2) (KAPA Biosystem, Boston, USA), 1 µL of each primer (10 pmol/ µL), 5.5 µL ddH2O, and 5 µL 
DNA template.    PCR amplification was  performed by following protocol: denaturation for 5 min at 94oC, 
amplification for 45 cycles consisting of 30 sec at 94oC, 30 sec at 52oC and 30 sec at 72oC and post extension at 
72oC for 7 min.  The amplified DNA then analyzed by 1.8% agarose gel electrophoresis and visualized using 
GelDoc (BioRad). Expected target product for this primer pair is ± 455 base pairs. 
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3. Result 
A total of 95 serum and plasma samples have been collected from the two facilities. The number and type of 
sample are adjusted to the availability of existing sample collections at the facilities. The origin of the samples 
are categorized into three types: 1) the samples from breeding facility at the PRC-IPB (Bogor 1, Bogor 2, Bogor 
3, Tangerang), 2) samples from performance monkeys (PRC’s collection), and 3) samples from confiscated 
monkeys (wildlife rescue center’s collection). The results of HBsAg and HBV DNA are presented in Table 1. 
Based on ELISA test for HBsAg, HBsAg was detected in 11 out of 95 long-tailed monkeys (11.6%) although 
none of those animal showed the presence of HBV DNA (Figure 1). 
Table 1: The prevalence of Hepatitis B infection in samples collected from the PRC-IPB and wildlife rescue 
center Bogor on a June 2014 until Februari 2015. 
Sample Origin 
Type of 
Sampel 
Number of 
Sampel 
Hepatitis B virus examination 
HBsAg VHB DNA 
PRC-IPB 
Bogor 1 Serum 8 0/8 - 
Bogor 2 Plasma 11 3/11 0/3 
Bogor 3 Plasma 25 2/25 0/2 
Tangerang Serum 30 0/30 - 
Performance monkey  Serum 4 1/4 0/1 
Wildlife Rescue Center 
Collection I Serum 4 0/4 - 
Collection II Plasma 13 5/13 0/5 
Total %   11,6% 0% 
 
 
Figure 1: The results of PCR amplification of viral hepatitis B Regio Pre-S1 in HBsAg seropositive samples. 
(1) individu T3336, (2) T3199, (3) T3331, (4) J190111B, (5) J300511C, (6) Nala, (7) Matu, (8) Pandu, (9) 
Brahma, (10) Awi, (11) TM SL3, (12) Positive control VHBHu, (13) Positive control VHBGi, (14) Positive 
control VHBOu, (15) Negative control. 
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4. Discussion 
HBsAg test was performed using commercial ELISA kits (HBsAg ™, Human®, Human fȕr Biochemica 
Gesellschaft und Diagnostica mbH, Germany) that utilized monoclonal antibody (mAb, mice) to human HBsAg. 
Monoclonal antibody is monospecific antibody that are identical because they are produced by one type of 
immune typel that are all clones of a single parent cell. Monoclonal antibodies have monovalent affinity, in that 
they bind to the same epitope, and has only one epitope [19]. From these definitions it can be said that the 
ELISA test used in this study are specific to binding human HBV surface antigen protein, so the hepatitis B 
virus were detected in M. fascicularis indicated has same surface antigen protein (gene S) with human HBV.  
Some cross-reaction possibility of monoclonal antibody on the ELISA test, that monoclonal antibody is specific 
for a single epitope, but may cross-react with epitopes having a similar three-dimensional structure. Monoclonal 
antibodies can also react with two different multiepitopic antigens if they share the particular epitope recognized 
by the monoclonal antibody. Detection of HBsAg by ELISA in M. fascicularis is have done reported, but can 
not detected HBsAg in Asian origin M. fascicularis [20], and reported have been detected in 4 of 21 M. 
fascicularis Mauritius Island origin with positive HBV DNA [10]. 
Based on the origin historical data, it is known that macaques with higher positive HBsAg are derived from the 
samples of confiscated and pets macaques, as much as 55% (6/11) compared with samples of captive macaques, 
45% (5/11). From these results, it is assumed that pet macaques are at higher risk to  infection.  Direct contact 
between NHP pets and their owners is often intimate, as pets climb about and clinging to their owners.Food 
sharing between pets and owners is common. These activities all have the potential to bring macaque body 
fluids, especially oral secretions, into contact with their owner’s mucus membranes, a potential portal of entry 
for infectious agents [13]. Hepatitis B virus is in bloodborne pathogen or pathogenic agents present in the blood 
or body fluids, so that this virus is transmitted through contact with blood products / fluids / mucous. Immunity 
system also affects the transmission of the disease, when in a stressful environmental conditions, high density 
and often in poor conditions,  which may compromise immunity and facilitate disease transmission [21]. 
Possible detection of hepatitis B virus surface antigen in M. fascicularis is not only caused by HBV transmission 
between M. fascicularis with humans. Some other possibilities are 1) the transmission of M. fascicularis with 
other non human primate species in their natural habitat, and 2) the possibility of indigenous/HBV natural 
infection. One indigenous hepatitis B have been reported in chimpanzees, where in 11 of 13 chimpanzees with 
chronic HBV infection looks are genetically different from human HBV genotype. Then when compared with 
other HBV primate species isolates, HBV chimpanzees have a typical nucleotide and different amino acid in 
whole genome and gene S which can quickly and accurately identify this strain [9]. 
Although HBV in primate species may be indigenous, but transmission to humans remains a concern. Certain 
publications also stated that gibbons, woolly monkey HBV strains, and human HBV can cause hepatitis B 
infection in chimpanzees. The potential for zoonotic disease transmission exists where blood or body fluid 
exposure is common, could include chronically infected animals kept as family pets, close contact with 
caretakers, or in situations in which chimpanzees are slaughtered and used as bushmeat [9]. 
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Failed to detection of HBV viral DNA can also be caused by a primer pair hepSF-1 and hepSR-out used in this 
study can not amplifying the viral DNA sample well. In a study of HBV in M. fascicularis Mauritius Island 
origin, the primer use of areas that overlap on the surface gene region and the core gene, which is highly 
conserved among all human HBV genotype [10]. This primer encodes a surface area gene (S gene) of 118 bp 
with a forward primer base sequence (5 'GGAGTGGGCCTCAGC CCGTTTCTC'3) at position 489-512 and 
reverse primer (5'GCCCCCAATACCACATCATCCATA'3) [16]. When compared to the primers used in this 
study, the forward primer SF1 HepB-encoding gene region PreS1 in positions 912-932 and reverse primer 
encoding gene region PreS1 in the position from 1348 to 1367. Meanwhile, when compared to the primers used 
by author [10] using the method of real time-PCR, that used the primers from the DNA sequence of overlapping 
between the core gene at position 1186 to 1203 and position 1266 - 1283. So the possibility of this differences in 
gene coded region that causes HBV DNA not amplified. Based on phylogenetic analysis, showed that HBV 
genomes of Mauritius Island long-tailed macaques clustered on human HBV. 
In addition, the positive HBsAg and negative HBV DNA can be interpreted as two possibilities: 1) the amount 
of virus in a sample is very low and 2) chronic infection. According to the authors in [22, 23] noted that the 
acute phase of infection, hepatitis B virus DNA can be detected in the blood by PCR at 3-5 weeks after 
exposure, and HBsAg will be detected in the blood 7- 9 weeks after exposure. HBV DNA concentration will be 
increased gradually with the increase of HBsAg, then will reach a peak during the acute infection. Then the 
concentration of serum HBsAg will decline to undetectable levels in 4-6 months, if the level of HBsAg remains 
persistent for more than 6 months, then it is categorized as a chronic infection. 
 In chronic infection, HBsAg will still be detected after more than 6 months. While HBV DNA can only be 
found in high levels in the serum during the phase of viral replication. But in non-replicating phase, HBV DNA 
only slightly or not can be detected in the serum [24]. Studies on a sample of gibbons show the results of 
HBsAg titers were very low, and the viral DNA with very low levels also indicate asymptomatic infection status 
careers with low infection [5]. 
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